Prof Brenda L Gallie, MD, FRCS, CM, OOnt is an expert in Ophthalmology at Hospital for Sick Children (Canada). As of September 2026, ScienceLeadR ranks Brenda L Gallie in the top 1% of experts worldwide for Eye Neoplasms, Retinal Diseases and Eye Diseases, Hereditary. Brenda L Gallie has authored 337 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 1,061 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Brenda L Gallie, MD, FRCS, CM, OOnt Hospital for Sick Children Canada
1 061 ScienceLeadR Reputation 1061
Network Map

Ophthalmology

Subspecialties: Oncology - Pediatrics - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1985 - 2026

Source: PubMed

Hospital for Sick Children

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 337

Citations

Citations: 20 236 1st author: 21 Last author: 134 Unique author: 6


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population-Based Report From CYP-C.
PMID 41968807 — retinoblastoma, neoplasms, diagnosis, child
Pediatr Blood Cancer20260
Timely and accurate RB1 genetic testing guides familial risk stratification in heritable retinoblastoma.
PMID 41667398 — research design, retinoblastoma, genetic testing
Ophthalmic Genet20260
Enhancing Circle-of-Care Communication in Pediatric Cancer Through Digital Health Technologies: A Scoping Review.
PMID 41137429 — caregivers, communication, neoplasms, electronic health records, health personnel, records, digital health
Pediatr Blood Cancer20250
Diffuse infiltrating retinoblastoma: a multicentre, international, data-sharing study.
PMID 40738737 — eye, retinoblastoma, ophthalmology, glaucoma, therapeutics
Br J Ophthalmol20251
Optic Nerve Invasion in Retinoblastoma: Impact of Eye Salvage and Adjuvant Chemotherapy.
PMID 40548635 — eye, retinoblastoma, ophthalmology, neoplasms, drug therapy, optic nerve, chemotherapy, adjuvant, diagnosis, therapeutics, child, chemotherapy
Invest Ophthalmol Vis Sci20250

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 1
Phase 2 1

By status:

Active not recruiting 1
Terminated 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map